Oslo, June 12, 2025 - Observe Medical ASA («Observe Medical» or the «Company») refers to the stock exchange announcements dated 11 June 2024 regarding the private placement.

Observe Medical is happy to announce the positive market reception of UnoMeter Safeti Plus. Since the first delivery in January 2025, the product has gained significant traction, reflecting strong demand and customer confidence. Key highlights include:

• Market Re-establishment: Sales have been re-established in countries representing 85% of Convatec's 2021 market for the product.
• Global Reach: Orders received from 27 countries, with 16 countries placing multiple/repeat orders. For the whole UnoMeter portfolio, the Company has received orders from 33 countries.
• Order Intake: Based on a 6-month rolling order intake, the company has achieved an annualized order intake of approximately NOK 30 million.
• Operational Focus: The company is focused on further penetrating this market, building on the success of UnoMeter Safeti Plus.
• Financing: With a successful private placement, strong support from our shareholders, and substantial backing from our creditors through a significant debt reduction, the company is positioned to advance its operational and strategic agenda, including the realization of UnoMeter Safeti Max and Sippi.

Please find the updated company presentation attathed. The presentation can also be found at www.observemedical.com.

For further information, please contact:

Jørgen Mann, CEO Observe Medical

Mobile: +45 408 67 558

E-mail: jorgen.mann@observemedical.com

Johan Fagerli, CFO Observe Medical

Mobile: +47 958 12 765

E-mail: johan.fagerli@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement and ultrasound, in combination with targeted M&A and distribution. Observe Medical is working with a network of leading distributors to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available at www.observemedical.com.